Search Results - Paner-Straseviciute, Agne

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    P-400 A Discrete Choice Experiment analysis to understand Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States

    P-400 A Discrete Choice Experiment analysis to understand Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States by Faiman, Beth, Le, Hoa, Laurent, Julie, Patel, Saurabh, Paner-Straseviciute, Agne, Zhang, Xinke, Mikhael, Joseph

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Panel Interview of Oncology Practices with Emergent Experience of Teclistamab in the Real World: The Tec-Pioneer Study

    Panel Interview of Oncology Practices with Emergent Experience of Teclistamab in the Real World: The Tec-Pioneer Study by Derman, Ben A, Roach, Meaghan, Lin, Dee, Wu, Bingcao, Murphy, Richard, Kim, Nina, Doyle, Margaret, Prood, Nadya, Fowler, Jessica, Marshall, Alexander, Jamaleddine, Amal, Paner-Straseviciute, Agne

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Real-World Characteristics and Outcomes in Patients with Multiple Myeloma Receiving Teclistamab Step-up Doses in Academic Vs. Community Settings

    Real-World Characteristics and Outcomes in Patients with Multiple Myeloma Receiving Teclistamab Step-up Doses in Academic Vs. Community Settings by Afrough, Aimaz, Khan, Adeel M, Chinaeke, Eric, Kim, Nina, He, Jinghua, Min, Elissa E., Wu, Bingcao, Lin, Dee, Paner-Straseviciute, Agne, Hester, Laura, Fowler, Jessica, Walker, Sian, Hearty, Christina, Anderson, Larry D

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Real-World Patient Characteristics and Outcomes in Patients with High-Risk Cytogenetic Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Practices in the US

    Real-World Patient Characteristics and Outcomes in Patients with High-Risk Cytogenetic Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Pract... by Dhakal, Binod, Kim, Nina, John, William, Wu, Bingcao, Lucht, Sarah, Lin, Dee, Bland, Emily, Paner-Straseviciute, Agne, Van Doren, Bryce, Hester, Laura, Giegerich, Sarah, Fowler, Jessica, Gash, Yul Brian, Walker, Sian, Klink, Andrew, Hearty, Christina, Feinberg, Bruce, Marshall, Alexander, Doyle, Margaret, Voorhees, Peter M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Real-World Patient Characteristics and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Practices in the US

    Real-World Patient Characteristics and Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab across Community Oncology Practices in the US by Dhakal, Binod, Kim, Nina, John, William, Wu, Bingcao, Lucht, Sarah, Lin, Dee, Bland, Emily, Paner-Straseviciute, Agne, Van Doren, Bryce, Hester, Laura, Giegerich, Sarah, Fowler, Jessica, Gash, Yul Brian, Walker, Sian, Klink, Andrew, Hearty, Christina, Feinberg, Bruce, Marshall, Alexander, Doyle, Margaret, Voorhees, Peter M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: the TecPIONEER Study

    Panel Interview of ONcology practices with Emergent Experience of teclistamab in the Real world: the TecPIONEER Study by Derman, Benjamin A, Roach, Meaghan, Lin, Dee, Wu, Bingcao, Murphy, Richard, Kim, Nina, Doyle, Margaret, Prood, Nadya, Fowler, Jessica, Marshall, Alexander, Jamaleddine, Amal, Paner-Straseviciute, Agne

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: